Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer

Catherine M. Bollard, Stephen Gottschalk, Ann M. Leen, Heidi Weiss, Karin C. Straathof, George Carrum, Mariam Khalil, Meng Fen Wu, M. Helen Huls, Chung Che Chang, M. Victoria Gresik, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop

Research output: Contribution to journalArticle

235 Scopus citations

Abstract

Epstein-Barr virus (EBV) - associated tumors developing in immunocompetent individuals present a challenge to immunotherapy, since they lack expression of immunodominant viral antigens. However, the tumors consistently express viral proteins including LMP2, which are immunologically "weak" but may nonetheless be targets for immune T cells. We previously showed that a majority of cytotoxic T lymphocytes (CTLs) reactivated using EBV-transformed B-lymphoblastoid cells lines (LCLs) contained minor populations of LMP2-specific T cells and homed to tumor sites. However, they did not produce remissions in patients with bulky disease. We have now used gene transfer into antigen-presenting cells (APCs) to augment the expression and immunogenicity of LMP2. These modified APCs increased the frequency of LMP2-specific CTLs by up to 100-fold compared with unmodified LCL-APCs. The LMP2-specific population expanded and persisted in vivo without adverse effects. Nine of 10 patients treated in remission of high-risk disease remain in remission, and 5 of 6 patients with active relapsed disease had a tumor response, which was complete in 4 and sustained for more than 9 months. It is therefore possible to generate immune responses to weak tumor antigens by ex vivo genetic modification of APCs and the CTLs so produced can have substantial antitumor activity. This study is registered at http://www. cancer.gov/clinicaltrials (protocol IDs: BCMH-9936, NCT00062868, NCT00070226).

Original languageEnglish (US)
Pages (from-to)2838-2845
Number of pages8
JournalBlood
Volume110
Issue number8
DOIs
StatePublished - Oct 15 2007

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Complete responses of relapsed lymphoma following genetic modification of tumor-antigen presenting cells and T-lymphocyte transfer'. Together they form a unique fingerprint.

Cite this